BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Boehringer Ingelheim
US Army

Generated: November 24, 2017

DrugPatentWatch Database Preview

LUVOX CR Drug Profile

« Back to Dashboard

Which patents cover Luvox Cr, and what generic Luvox Cr alternatives are available?

Luvox Cr is a drug marketed by Jazz Pharms and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.

This drug has twenty-four patent family members in eighteen countries.

The generic ingredient in LUVOX CR is fluvoxamine maleate. There are eleven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the fluvoxamine maleate profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jazz Pharms
fluvoxamine maleate
CAPSULE, EXTENDED RELEASE;ORAL022033-001Feb 28, 2008DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Jazz Pharms
fluvoxamine maleate
CAPSULE, EXTENDED RELEASE;ORAL022033-002Feb 28, 2008DISCNYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for LUVOX CR

Drugname Dosage Strength RLD Submissiondate
fluvoxamine maleateExtended-release Capsules100 mgLuvox CR4/20/2009
fluvoxamine maleateExtended-release150 mgLuvox CR4/13/2009

International Patent Family for Tradename: LUVOX CR

Country Document Number Estimated Expiration
Russian Federation2275191► Subscribe
South Africa200110401► Subscribe
Germany60035579► Subscribe
Algeria3256► Subscribe
European Patent Office1178780► Subscribe
European Patent Office1852111► Subscribe
Canada2698347► Subscribe
Australia782059► Subscribe
Austria367153► Subscribe
Czech Republic20014618► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus